Abstract: Some new fluorine-substituted 3,5-disubstituted amino-1,2,4-triazines have been obtained from arylamination of 2,2,2-trifluoro-N-[2-(5-hydroxy-3-thioxo-2,3-dihydro-1,2,4-triazin-6-yl)-4-nitrophenyl] acetamide followed by ammonolysis to produce N- (2-(5-amino-3-(arylamino)-1,2,4-triazin-6-yl)-4-nitrophenyl)-2,2,2-trifluoroacetamides which reacted with N-phenylthiourea. The structures of products were deduced from their elemental analysis and spectral measurements. The new lamotrigine analogs were evaluated in vitro as antibacterial. Interestingly, some compounds showed interesting activity against the Bacillus subtilis, Streptococcus faecalis, Micrococcus luteus, and Staphylococcus aureus bacteria.
Introduction
In recent years, there has been increasing interest in the design of new drugs as to inhibition of the resistance of microbial towards the drugs were used. Among these drugs, Lamotrigine drug (3,5-diamino-6-(2`,4`-dichlorophenyl)-1,2,4-triazine) ( Fig. 1) this is used as antiepileptic, bipolar disorder [1] [2] [3] [4] , anticonvulsant, neurological lesions and act as a tranquilizer as well as behaves an effective mood stabilizer 5, 6 . Also, Lamotrigine and its ammonium salt complexes used as antimicrobial activity 7 .
Figure 1. Lamotrigine drug
Recently, Makki et al. 8, 9 reported a simple route to synthesize Lamotrigine analogs as an antiinflammatory and antioxidant agent. 1,2,4-triazine nucleus is scaffold of various biological activities, also have a significant variety of pharmaceutical properties, such as antitumor 10 , anti-HIV, antimicrobial 11 . Also, isoxazole, 1,2,4-triazole, and benzo [d] imidazole cores have a significant role in towads bacteria [12] [13] [14] .
Moreover, thiourea moieties play a role of biological activity involving antibacterial 15 , antifungal 15, 16 , antitubercular 17 , antithyroid 18 , and insecticidal agents 19 .
Therefore, there is a need to develop an improved process for producing lamotrigine analogs that reduce the manufacturing cost and batch cycle time 20 . Thus, the present work describes a short route to obtain some new lamotrigine analogs as fluorine, arylamines, and N-phenylthioureas substituents given their antibacterial activity.
Results and Discussion
In the present work in the search for new highly bioactive drugs, fluorine substituted 3,5-disubstituted amino-1,2,4-triazines 11-14 as a lamotrigine analogs have been synthesized and evaluated as antibacterial probes. The starting material 2,2,2-trifluoro-N-[2-(5-hydroxy-3-thioxo-2,3-dihydro-1,2,4-triazin-6-yl)-4-nitrophenyl] aceta-mide 2 obtained from refluxing of 6-(2-amino-5-nitrophenyl)-3-thioxo-3,4-dihydro-1,2,4-triazin-5 (2 H)-one 1 with ethyl 2,2,2-trifluoroacetate in THF. Compound 1 also preparing 21 by refluxing 5-nitroisatin with thiosemicarbazide in aq. NaOH Scheme 1.
A simple primary arylamines such as 3,4-dimethylisoxazol-5-amine, 4H-1,2,4-triazol-3-amine, 1H-benzo[d]imidazol-2-amine, and 4-amino-3-hydroxynaphthalene-1-sulfonic acid towards 2,2, 2-trifluoro-N-[2-(5-hydroxy-3-thioxo-2,3-dihydro-1,2,4-triazin-6-yl)-4-nitrophenyl]acetamide 2 in refluxing isopropyl alcohol led to the formation 3-(substituted-amino)-5-hydroxy-6-aryl-1,2,4-triazines 3-6 Scheme 2.
On the other hand, aminolysis of compounds 3-6 by refluxing with NH3/EtOH afforded the 5-amino-3-(substituted-amino)-6-aryl-1,2,4-triazines 7-10 as lamotrigine analogs Scheme 3.
Finally, reaction of compounds 7-10 with N-phenylthiourea in DMF furnished 2,2,2-trifluoro-N- [2-(3-(substituted- (Fig. 2) . Furthermore, FT-IR spectra of the compounds 3-6 showed a new exo-NH at ῡ 3350 ~3190 cm -1 .
Moreover, the 1 H NMR spectrum of 3-6 exhibited δ at 8.59 ~ 8.33 ppm for exo NH. 13 C NMR of compounds 3-6 indicated that disappeared C=S, all of these shreds of evidence confirmed that structures of 3-6, and the arylamination of compound 2 occurred.
Structures of lamotrigine analogs 7-10 established from the presence of the vibration bands at 3441 ~3412 and 3342 ~3300 cm -1 (stretching of NH2) with lacks of OH group. Also, 1 H NMR of 7-10 showed resonated signals at δ 4.14-4.13 ppm attribute to NH2. Exhibition of signals at δ 178 ~ 176 ppm in 13 C NMR of compounds 11-14 indicated that the presence of C=S of thiourea and confirmed the reaction of compounds 7-10 with N-phenylthiourea happened. 19 F NMR spectra of all compounds 1-14 showed δ -78 ~ -75 ppm attribute to CF3.
Finally, the newly synthesized lamotrigine analogs (7) (8) (9) (10) (11) (12) (13) (14) were screened for their in vitro antibacterial activity against four bacterial isolated Bacillus subtilis, Streptococcus faecalis, Micrococcus luteus, and Staphylococcus aureus. The results of the study revealed that the compounds 7-14 showed significant antibacterial potency.
As expected, compounds 12 and 13 were showed excellent activity against B. subtilis and S. faecalis bacteria, due to the presence of 1,2,4-triazine, CF3, thiourea, and 1,2,4-triazole and/ or benzo[d]imidazole moieties. On the other hand, 3-hydroxynaphthalene moiety in compounds 10 and 14 may be reduced their biological activity against the tested bacteria, because of these compounds had the lowest activities among the other synthesized compounds. The result is shown in Table 1 . Table 1 . In vitro antibacterial activity.
Conclusion
5-Amino-3-(substituted-amino)-6-(fluoro/nitro) aryl-1,2,4-triazine and their derivatives were synthesized and evaluated against four isolated bacteria (B. subtilis, S. faecalis, M. luteus, and S. aureus). Some compounds exhibited a good activity towards the tested bacteria.
Experimental
All chemicals purchased from Merck and Fluka and used as received without any further purification. The melting points recorded by Stuart scientific SMP30 (Bibby, UK) melting point apparatus and reported as uncorrected. A Perkin Elmer model RXI-FT-IR 55,529 cm −1 used for recording the IR spectra. A Brucker advance DPX 400 MHz using TMS as an internal standard used for recording the 1 H, 13 C, and 19 F NMR spectra at (400 MHz), (100 MHz), and (84.25 MHz) respectively in DMSO-d6 (δ in ppm) as a solvent. Elemental microanalysis was performed on a PerkinElmer CHN-2400 analyzer. TLC analyses were performed on Merck silica gel 60 F254 aluminum plates with hexane/ethyl acetate mixtures. Compounds 1 and 2 were obtained according to the reported method 9 .
Synthesis of 3-(Substituted-amino)-5-hydroxy-6-aryl-1,2,4-triazines 3-6
In a round-bottom flask, an equimolar amount of compound 2 and 3,4-dimethylisoxazol-5-amine, 4H-1,2,4-triazol-3-amine, 1H-benzo[d]imidazol-2-Amine, and 4-amino-3-hydroxynaphthalene-1-sulfonic acid were dissolved in isopropyl alcohol (70 mL) then heated under reflux for 6 h. The progress of the reactions was monitored by TLC. After completion of the reactions, colled at room temperature. The resulting solid was filtered off in a Buchner funnel, then washed with small amounts of cooled water and dried. Finally, the products crystallized from suitable solvents to give compounds 3-6. N-[2-(3-((4H-1,2,4-Triazol-3-yl) Orange crystals (EtOH), yield 3.526g, 78%, M.p: 254-256°C.
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3-Hydroxy-4-((5-hydroxy-6-(5-nitro-2-(2,2,2-trifluoroacetamido)phenyl)-1,2,4-triazin-3-yl) amino)naphthalene-1-sulfonic acid 6:
Black crystals (EtOH), yield 5 
Synthesis of 5-Amino-3-(substituted-amino)-6-aryl-1,2,4-triazines 7-10
In a round-bottom flask, a mixture of compounds 3-6 (6.5 mmol) and ammonia (37%, 40 ml) in ethanol (50 ml) heated under reflux for 4-6 h. Progress of the reactions was monitored by TLC. After completion of the reactions, cooled at room temperature then poured onto ice-drops AcOH. The yielded solids filtered off in a Buchner funnel, then washed with a small amount of cooled water, dried. Finally, the products crystallized from proper solvents, to give compounds 7-10 respectively. -3-((3,4-dimethylisoxazol-5-yl)  amino)-1,2,4-triazin-6-yl)-4-nitrophenyl) In a round-bottom flask, equimolar amounts of compounds 7-10 and N-phenylthiourea in DMF (40 ml) heated under reflux for 3 h. Progress of the reactions was monitored by TLC. After completion of the reactions, colled at room temperature then poured onto ice. The resulting solids filtered off in a Buchner funnel, then washed with small amounts of cooled water, dried. Finally, the products crystallized from suitable solvents to give compounds 11-14, respectively. 3-((3,4-Dimethylisoxazol-5-yl)amino)-5-(3-phenylthioureido)-1,2,4-triazin-6-yl) 
N-(2-(5-Amino
N-[2-(
The antibacterial activity
The in vitro antimicrobial activity of lamotrigine analogs 7-14 was screened against some selected bacterial (Bacillus subtilis, Streptococcus faecalis, Micrococcus luteus, and Staphylococcus aureus) by the reported method. The suspension of each microorganism rubbed onto the surface of solidified nutrient agar already set into Petri dishes with swap stick.
The stock solution suitably diluted to get dilution of 5 µg/mL concentration (DMSO) of the tested compounds 7-14. Wells (6 mm in diameter) dug in the agar media with the help of a sterile metallic borer. Ampicillin 200 µg/mL used as controls. The wells incubated immediately at 37° C for 48 h. The activity determined by measuring the diameter of zones indicating complete inhibition (mm) and comparing the values with the standard.
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